<?xml version="1.0" encoding="UTF-8"?>
<p id="par0005">Respiratory syncytial virus (RSV) is an ubiquitous RNA virus infection that is a major cause of lower respiratory tract disease in children under 5 years of age worldwide (
 <xref rid="bib0135" ref-type="bibr">Nair et al., 2010</xref>; 
 <xref rid="bib0180" ref-type="bibr">Shi et al., 2015</xref>). The estimated global burden of RSV associated acute lower respiratory tract infection (ALRI) in 2015 in under 5 year olds is 33.0 million (21.6–50.3), most of which occurs in developing countries (30.5 million) (
 <xref rid="bib0185" ref-type="bibr">Shi et al., 2017</xref>). Of the 3.2 (2.7–3.8) million hospital admissions associated with RSV in the under 5 s, 1.4 (1.2–1.7) million occurred in the 0–5 months age group, and 1.2 (1.0–1.5) million occurred in developing countries.
</p>
